Back to search

United Kingdom· GB-APID-397611000001105

Alomide 0.1% eye drops

A lodoxamide product containing lodoxamide, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 4 of our 19 countries.

ATC S01GX05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedAlomide 0.1% eye dropsATCS01GX05REGISTER NO.GB-APID-3976110000011…PACKS LISTED3CHECKEDSeptember 13, 2026

Where it is registered

Lodoxamide is registered in 4 of 19 countries.

Countries holding a registration under ATC S01GX05 (lodoxamide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Lodoxamide · ATC S01GX05

4 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Lodoxamide
Manufacturer
Novartis Pharmaceuticals UK Ltd
Country
United Kingdom (GB)
ATC code
S01GX05
ATC class
Lodoxamide
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5015664024335
  • gtin
    5010678901085
  • gtin
    7613421033927

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lodoxamide in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lodoxamide products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Belgium · Alomide
  • Finland · Alomide
  • Hungary · Alomide
  • Luxembourg · Alomide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8b9db88-6510-408a-8edb-33ff59a6d774
GET /v1/drugs/e8b9db88-6510-408a-8edb-33ff59a6d774?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "397611000001105",
  "desc": "Alomide 0.1% eye drops (Novartis Pharmaceuticals UK Ltd)",
  "form": "Eye drops",
  "vpid": "42192611000001104",
  "source": "dmd",
  "vtm_id": "776561002",
  "strength": "1 mg",
  "substance": "Lodoxamide",
  "ingredient": "Lodoxamide trometamol",
  "supplier_code": "2920101000001102"
}

See everything about lodoxamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.